Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
about
Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder CancerC-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewPrognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisPretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-AnalysisThe elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patientsPrognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study.Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score.Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosisLow-grade dietary-related inflammation and survival after colorectal cancer surgery.Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancerLiver inflammation and metabolic signaling in ApcMin/+ mice: the role of cachexia progression.Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival.Platelet-Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast CancerPrognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer.A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.Living well with medical comorbidities: a biopsychosocial perspective.The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis.The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers.Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agentsDerived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization.The role of chronic inflammation in obesity-associated cancers.Markers of systemic inflammation predict survival in patients with advanced renal cell cancer.A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patientsGlasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer.Prognostic value of preoperative neutrophil-lymphocyte ratio is superior to platelet-lymphocyte ratio for survival in patients who underwent complete resection of thymic carcinoma.Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancerAn inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancerNeutrophil and lymphocyte counts at diagnosis are associated with overall survival of pancreatic cancer: A retrospective cohort studyClinical implications of systemic inflammatory response markers as independent prognostic factors in colorectal cancer patients.The role of the systemic inflammatory response as a biomarker in immunotherapy for renal cell cancer.The effects of obesity and obesity-related conditions on colorectal cancer prognosis.Low lymphocyte-to-white blood cell ratio and high monocyte-to-white blood cell ratio predict poor prognosis in gastric cancer.Use of inflammatory markers to guide cancer treatment.C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis.Prognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studies.The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer.Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
P2860
Q26765951-272B4FF5-6042-45C7-B4BA-CD94B16F56D1Q26771557-18731D58-6FC5-434C-89C4-B326BB797DC8Q27022482-22D531A6-093A-44A8-9FBA-2978B90DE85BQ28070039-CA767D19-BA26-4AB2-82A1-61DAAAF34694Q33613591-A2A8A2EB-0AAC-4844-952F-2370C6488259Q33673109-7BD1F96F-DDFC-47A9-9B82-F9D4281FB8C4Q33911737-2D7E57BC-8F4D-41E3-A410-DC93E37519F8Q34005728-29105A9C-C9CD-443B-872D-F6F9EC6A5844Q34038212-CA345603-152D-47BC-A971-2EB81E5B3D05Q35002416-96CA375F-E1A4-42BC-A832-61046EC24775Q35196068-F5DD70A1-3062-465C-87E4-0474D987CCF5Q35921785-15509216-48D5-4152-8D63-D06480836D58Q36089813-E1EF0A02-D696-47F0-AD74-4F8CCD28B2C9Q36089994-40E573D1-D942-4480-B4B1-ECE1AD475E2BQ36166771-0FCA6C34-9A1F-432A-A04C-CB13A8F3788CQ36186701-9B7095B6-5E55-47DB-A2E9-52A9849932D2Q36231894-FC061B05-ACB2-4EF1-BD1B-B51F84C0E061Q36252250-E8908A58-BA7A-465E-A71C-65216AE146C0Q36257462-7F8F117D-5317-4DD2-A0DF-848DDA523A0FQ36343047-97424DB0-B6A6-4DA9-9A2E-9F659A826B79Q36824936-502C20E8-25E8-4134-9195-4217AD329B80Q36931512-98D69D0C-F1FD-4D79-A14C-400A799912C9Q37003374-21727C5F-3DF7-473C-8332-DD163F483932Q37040673-AA3BA58D-6A75-408A-8AE5-3E76D3A65EC5Q37045528-C992B0CA-34D7-4ED7-AC20-D6F8AF426509Q37121547-A8233261-20E6-4F02-B839-8240ACD849B4Q37152525-83914448-1776-41F3-8850-190A3D919FBFQ37152934-6DE2D10D-C4CF-4389-A4C3-797BA79441ABQ37177861-F436D8BE-5717-4CA6-B9E4-12907CE7862EQ37328875-70F3CA74-9EBE-47D7-BBAF-0E3449C2E957Q37570378-9000EC8F-247C-449D-BFED-BEC1F7543FBDQ37605784-7C3EBDE8-1C25-4CB6-95E4-98D492CA15ACQ37654680-0AC8CFD8-9CAA-4A6E-A645-97E0F465B93BQ37706341-D2EEB78D-1059-4C22-B75D-73888A03B681Q37903224-71479CFC-29E0-40CA-B7B4-8A235FBF2CB6Q38232944-73F74A10-A77C-4957-BC5E-3F60D2A44CBDQ38369552-57A03332-59BD-449A-8821-DD02F268F52EQ38980174-A86160F6-BB74-4977-9828-F27327FDC2A2Q39041165-F5BF6CEC-7B84-4BB9-BB61-288A07A07A92Q39050892-DC498C3B-320B-4307-9EEF-563F7311491C
P2860
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Comparison of the prognostic v ...... atients with colorectal cancer
@ast
Comparison of the prognostic v ...... atients with colorectal cancer
@en
type
label
Comparison of the prognostic v ...... atients with colorectal cancer
@ast
Comparison of the prognostic v ...... atients with colorectal cancer
@en
prefLabel
Comparison of the prognostic v ...... atients with colorectal cancer
@ast
Comparison of the prognostic v ...... atients with colorectal cancer
@en
P2093
P2860
P921
P356
P1476
Comparison of the prognostic v ...... atients with colorectal cancer
@en
P2093
Anderson JH
Chakrabarti M
Crozier JE
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604027
P407
P577
2007-10-09T00:00:00Z